Effects of 3-acetylpyridine on the central nervous system of the rat, as demonstrated by silver methods.
D000085:Acetates; D000818:Animals; D001921:Brain / Q000473:pathology*; D002490:Central Nervous System / Q000187:drug effects*; D002493:Central Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology; D002529:Cerebellar Nuclei / Q000473:pathology; D005154:Facial Nerve / Q000473:pathology; D005260:Female; D005930:Glossopharyngeal Nerve / Q000473:pathology; D008297:Male; D008526:Medulla Oblongata / Q000473:pathology; D009434:Neural Pathways / Q000473:pathology; D009475:Neurons, Afferent; D009847:Olivary Nucleus / Q000473:pathology; D011725:Pyridines; D051381:Rats; D012154:Reticular Formation / Q000473:pathology; D013378:Substantia Nigra / Q000473:pathology; D014630:Vagus Nerve / Q000473:pathology
D000085:Acetates; D011725:Pyridines